Safety of guselkumab in Inflammatory Bowel Disease up to 1 year: Integrated safety analysis of phase 2 and 3 studies in Crohn's Disease and Ulcerative Colitis

被引：0
|
作者：
Sands, B. E. [1 ]
Panaccione, R. [2 ]
Danese, S. [3 ,4 ]
Panes, J. [4 ,5 ]
Hisamatsu, T. [5 ,6 ]
D'Haens, G. [6 ,7 ]
Van Rampelbergh, R. [7 ,8 ]
Olurinde, M. [8 ,9 ]
Yee, J. [8 ,9 ]
Baker, T. [8 ,9 ]
Yarandi, S. [8 ,9 ]
Germinaro, M. [8 ,9 ]
Vetter, M. L. [8 ,9 ]
Li, H. [8 ,9 ]
Ballina, M. Rosas [9 ,10 ]
Allegretti, J. [10 ,11 ,12 ]
Afzali, A. [12 ,13 ]
Rubin, D. T. [13 ]
机构：
[1] Ichan Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY USA
[2] Univ Calgary, Div Gastroenterol, Inflammatory Bowel Dis Unit, Calgary, AB, Canada
[3] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[4] Univ Vita Salute San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[5] Hosp Clin Barcelona, IDIBAPS CIBERehd, Barcelona, Spain
[6] Kyorin Univ, Sch Med, Med Ctr, Tokyo, Japan
[7] Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
[8] Janssen Res & Dev, Immunol, Antwerp, Belgium
[9] Janssen Res & Dev, Immunol, Spring House, PA USA
[10] Actelion Res & Dev, Immunol, Allschwil, Switzerland
[11] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
[12] Harvard Med Sch, Div Gastroenterol Hepatol & endoscopy, Boston, MA USA
[13] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0782
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0608
引用
收藏
页码：i1206 / i1208
页数：3
相关论文
共 50 条
  • [41] SAFETY OF GUSELKUMAB IN PATIENTS WITH PSORIATIC DISEASE: AN INTEGRATED ANALYSIS OF 11 PHASE 2 AND 3 CLINICAL STUDIES IN PSORIASIS AND PSORIATIC ARTHRITIS
    Strober, Bruce
    Coates, Laura
    Yu, Jenny
    Rowland, Katelyn
    Leibowitz, Evan
    Miller, Megan
    Kollmeier, Alexa
    Li, Shu
    Wang, Yanli
    Chan, Daphne
    Chakravarty, Soumya
    Yang, Ya-Wen
    Shawi, May
    Lebwohl, Mark
    Rahman, Proton
    RHEUMATOLOGY, 2023, 62
  • [42] Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of 11 Phase 2/3 Clinical Studies in Psoriasis and Psoriatic Arthritis
    Strober, Bruce
    Coates, Laura
    Yu, Jenny
    Rowland, Katelyn
    Leibowitz, Evan
    Miller, Megan
    Kollmeier, Alexa
    Li, Shu
    Wang, Yanli
    Chan, Daphne
    Chakravarty, Soumya
    Yang, Ya-Wen
    Shawi, May
    Lebwohl, Mark
    Rahman, Proton
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4199 - 4202
  • [43] Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis
    Ardizzone, S
    Bollani, S
    Bettica, P
    Bevilacqua, M
    Molteni, P
    Porro, GB
    JOURNAL OF INTERNAL MEDICINE, 2000, 247 (01) : 63 - 70
  • [44] Immunological status of the stomach in inflammatory bowel disease - Comparison between ulcerative colitis and Crohn's disease
    Ando, Takafumi
    Watanabe, Osamu
    Nobata, Kazuo
    Ishiguro, Kazuhiro
    Maeda, Osamu
    Ishikawa, Daisuke
    Hasegawa, Motofusa
    Kondo, Shinya
    Kato, Tsuyoshi
    Ohmiya, Naoki
    Niwa, Yasumasa
    Goto, Hidemi
    DIGESTION, 2008, 77 (3-4) : 145 - 149
  • [45] Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease
    Orholm, M
    Fonager, K
    Sorensen, HT
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (11): : 3236 - 3238
  • [46] Validation and reliability of the Turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn's disease
    Kani, Haluk Tarik
    Ergenc, Ilkay
    Arikan, Huseyin
    Komesli, Zeynep
    Seyrek, Berfin
    Demirtas, Coskun Ozer
    Alahdab, Yesim Ozen
    Imeryuz, Nese
    Atug, Ozlen
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31 (08): : 566 - 572
  • [47] Pr3-ANCA in Inflammatory Bowel Disease: A Useful Marker to Differentiate Ulcerative Colitis From Crohn's Disease?
    Mahler, Michael
    Seaman, Andrea
    Bogdanos, Dimitrios P.
    Pavlidis, Polychronis
    Shums, Zakera
    Forbes, Alastair
    Norman, Gary L.
    GASTROENTEROLOGY, 2011, 140 (05) : S692 - S692
  • [48] A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis
    Peyrin-Biroulet, L.
    Arkkila, P.
    Armuzzi, A.
    Atreya, R.
    Danese, S.
    Ferrante, M.
    Guardiola, J.
    Jahnsen, J.
    Louis, E.
    Lukas, M.
    Reinisch, W.
    Roblin, X.
    Smith, P. J.
    Kwon, T. S.
    Kim, J. Y.
    Yoon, S. W.
    Kim, D. H.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I1116 - I117
  • [49] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age
    Yajnik, Vijay
    Khan, Nabeel
    Dubinsky, Marla
    Axler, Jeffrey
    James, Alexandra
    Abhyankar, Brihad
    Lasch, Karen
    ADVANCES IN THERAPY, 2017, 34 (02) : 542 - 559
  • [50] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
    Vijay Yajnik
    Nabeel Khan
    Marla Dubinsky
    Jeffrey Axler
    Alexandra James
    Brihad Abhyankar
    Karen Lasch
    Advances in Therapy, 2017, 34 : 542 - 559
12345